疟原虫蚊阶段虫体表面蛋白P25和P21/P28与传播阻断疫苗
被引量:3
出处
《中国人兽共患病杂志》
CSCD
北大核心
2002年第4期113-114,123,共3页
Chinese Journal of Zoonoses
基金
国家自然科学基金资助项目 (3 0 0 70 718)
参考文献27
-
1[1]WHO.World Malaria Situation in 1994.Weekly Epidemiological Record[M].WHO,1997.
-
2[2]Kaslow DC.Acquired immunity to sexual stages. In:Sherman Iw(ed).Malaria parasite biology,pathogenesis,and Protection[M].ASM press,Washington,DC,1998,457.
-
3[3]Kaslow DC.Transmission-blocking vaccines.In:Hoffman SL(ed).Malaria vaccine development:a multiimmune response approach[M].ASM Press,Washington,DC,1996,181.
-
4[4]Ranawaka G,R Alejo Blanco,RE Sinden.The effect of a transmission-blocking antibody ingested in primary and secondary bioodfeeds upon the development of piasmodium berghei in the mosquito vector[J].Parasitology,1993,107:225.
-
5[5]Healer J,D Mcguinness,P Hopcroft,et al.Complement-mediated lysis of plasmodiumfalciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230[J].Infect Immun,1997,65:3017.
-
6[6]Sinden RE.Gametocytes and sexual development.In:Sherman IW(ed).Malaria parasite biology,pathogenesis,and protection[M].ASM Press,Washington,DC,1998,25.
-
7[7]kaslow DC,C Syin,TF McCutchan,et al. Comparison of the Primary structure of the 25 kDa ookinete surface antigens ofPlasmodiumfalciparumand Plasmodiumgallinaceumreveal six conserved regions[J].Mol Biochem Parasitol,1989,33:283.
-
8[8]Duffy PE,PPimenta,DC Kaslow.Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies[J].Exp Med,1993,177:505
-
9[9]Tsuboi T,DC Kaslow,YM Cao et al. Comparison of Plasmodiumyoeliiookinete surface antigens with human and avian malarria parasite homologues reveals two highly conserved regions[J].Mol Biochem Parasitol,1997,87:107.
-
10[10]Stowers AW,Keister DB,Muratova O,et al.A region of plasmodiumfalciparumantigen Pfs25 that is the target of highly potent transmission-blocking antibodies[J].Infect Immun,2000,68:5530.
同被引文献42
-
1Mark S, Fradin MD. Mosquitoes and mosquito repellents: a clinician's guide [J]. Ann Intern Med, 1998,128: 931 - 940.
-
2Phillips RS. Current status of malaria and potential for control [J].Clin Microbiol Rev, 2001, 14(1) :208 - 226.
-
3Altaf A. Lal, Pamela S.Patterson, John B.Sacci, et al. Anti mosquito midgut antibodies block development of Plasmodium falciparum and Plasmodium vivax in multiple species of Anopheles mosquitoes and reduce vector fecundity and survivorship[J] .PNAS 2001, 98 (9): 5228 - 5233.
-
4Carole A. Long, Stephen L Hoffma. Malaria - from infants to genomics to vaccines [J]. Science, 2002, 297: 345 - 347.
-
5Almeida APG, Peter F Billingsley.Induced immunity against the mosquito Anopheles stephensi Liston (Diptera: Culicidae) :effects on mosquito survival and fecundity[J]. Int J Parasitol, 1998, 28:1721- 1731.
-
6Gakhar SK, Gulia M.Anti- mosquito egg antibodies reduce the fecundity and viability in malaria Vector A. Stephensi (Diptera, Culicidae) [J]. J Immunol Immunopathol, 2001, 3: 53 - 56.
-
7Monika Gulia, Amita Suneja, Surendra K. Gakhar. Effects of anti mosquito hemolymph antibodies on fecundity and on the infectivity of malaria parasite Plasmodium vivax to Anopheles stephensi (Diptera:insecta) [J] .Jpn Infect Dis, 2002, 55:78 - 82.
-
8Ramasamy RK et al. Antigenic similarity between the mosquito vectors of malaria and filariasis [J]. J Med Entomol, 1991, 28:760 -762.
-
9Amita Suneja, Monika Gulia, S K Gakhar. Blocking of malaria parasite development in mosquito and fecundity reduction by midgut antibodies in Anopheles stephensi(Diptera: Culicidae ) Arch [J]. Insect Biochem Physiol, 2003, 52: 63 - 70.
-
10Simon Wilkins, Peter F.Billingsley. Partial characterization of oligosaccharides expressed on midgut microvillar glycoproteins of the mosquito, Anopheles stephensi Liston. Insect Biochem. Mol. Biol, 2001, 31: 937 - 948.
引证文献3
-
1赵卿,杨玉荣.抗蚊虫疫苗的研究进展[J].中国人兽共患病杂志,2004,20(6):540-542.
-
2李萍,马亚茹,陆俭,雷清,陈勇,蒋琳.Pfs25蛋白单克隆抗体的制备及双抗体夹心ELISA的建立[J].细胞与分子免疫学杂志,2011,27(12):1330-1334. 被引量:10
-
3刘东涌,罗恩杰.中国间日疟疾疫苗的发展现状及展望[J].日本医学介绍,2004,25(2):89-92. 被引量:2
二级引证文献12
-
1雷清,陈勇,刘晓,郭敏,蒋琳.恶性疟原虫pfs25多拷贝基因在毕赤酵母中的表达分析[J].生物技术,2012,22(3):23-27. 被引量:4
-
2胡琳洁,郭晓雅,侯美娜,邵成,史皆然.评价空肠弯曲菌外膜蛋白PEB1介导的重组BCG与上皮细胞的结合能力[J].现代生物医学进展,2011,11(10):1810-1812. 被引量:1
-
3陈勇,陆俭,李刚,雷清,蒋琳.构建真核表达载体实现恶性疟原虫膜蛋白pfs25在CHO细胞中的重组表达[J].药物生物技术,2013,20(1):12-16. 被引量:1
-
4解婷,薛莹,樊爱琳,简文.比较口服不同亲和力重组耻垢分支杆菌调节免疫的差异[J].现代生物医学进展,2013,13(8):1435-1438. 被引量:1
-
5陈勇,李萍,张予超,雷清,蒋琳.聚丙烯酰胺凝胶电泳分离恶性疟原虫pfs25膜蛋白的免疫原性研究[J].中国免疫学杂志,2013,29(7):694-696.
-
6雷清,刘晓,陈勇,梁凌宇,马超,蒋琳.恶性疟原虫Pfs25蛋白在毕赤酵母中高效分泌表达策略的研究[J].中国新药杂志,2013,22(22):2635-2640. 被引量:2
-
7李刚,高雪峰,周晖国,陈俏丽,王爱秀,陈勇.恶性疟原虫合子/动合子表面25蛋白自身偶联条件的优化及其聚体蛋白的制备[J].微生物学免疫学进展,2018,46(6):40-45.
-
8陈勇,陈俏丽,雷清,杨军,李刚,蒋琳.恶性疟原虫Pfs25基因在毕赤酵母中三拷贝串联分泌表达[J].中国新药杂志,2014,23(14):1622-1627.
-
9李爱萍,朱丽雯,张娟,周建伟.辣根过氧化物酶标记JWA抗体及其在免疫检测反应中的应用[J].药学与临床研究,2015,23(2):137-140. 被引量:2
-
10李小宇,张春雨,郭东全,张淋淋,尤晴,董英山,王永志,李启云.双抗夹心ELISA检测转Bar基因抗除草剂大豆[J].食品科学,2016,37(4):222-225. 被引量:9
-
1杜津,王东旭,程莉.疟疾疫苗的研究进展[J].国际流行病学传染病学杂志,2008,35(3):215-216.
-
2张本光,刘丽娟,公茂庆.疟疾传播阻断疫苗的研究进展[J].中国媒介生物学及控制杂志,2010,21(6):627-630.
-
3罗树红.疟原虫传播阻断免疫的研究进展[J].国外医学(寄生虫病分册),1996,23(3):100-103. 被引量:4
-
4王又红.疟疾传播阻断疫苗的研究现状和应用前景[J].国外医学(寄生虫病分册),1998,25(6):245-249. 被引量:2
-
5曹俊(综述,高琪(审校).疟疾疫苗现场试验研究进展[J].中国寄生虫学与寄生虫病杂志,2008,26(6):472-475. 被引量:5
-
6朱国鼎,曹俊,周华云,高琪.传疟媒介防制技术研究进展[J].中国血吸虫病防治杂志,2013,25(3):312-315. 被引量:7
-
7刘倩颖,孙立新.干扰性疟疾疫苗的研究进展[J].中国媒介生物学及控制杂志,2015,26(1):104-107.
-
8冯辉,朱晓彤,曹雅明.间日疟疫苗主要候选抗原的研究进展[J].国外医学(寄生虫病分册),2005,32(2):69-72. 被引量:2
-
9郑丽,徐卫民,刘英杰,杨毅梅,曹雅明.间日疟原虫传播阻断疫苗候选抗原Pvs25中国分离株高度保守[J].中国寄生虫学与寄生虫病杂志,2004,22(1):16-19. 被引量:7
-
10黄亚铭,毛玮,林康明,韦海艳,杜进发,覃业新,林珍.国内两株食蟹猴疟原虫传播阻断基因Pvs25和Pvs28比较分析[J].广西预防医学,2006,12(1):35-35.